RankAlpha logo
Back to Rankings

LQDA

LiquidiaB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The bull case rests on strong YUTREPIA uptake, rapid sequential sales growth, expanding prescriber adoption, improving profitability, and potential upside from L606 and additional indications. Company-reported Q2 results provide strong primary-source support.
Posture
Constructive
Lead driver
Sentiment
What changed
3 setup hits (3d) with net bullish as of 2026-09-09.
What can break
Analyst estimate, rating, and target revisions are unavailable.
Momentum
18
Value
58
Sentiment
78
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $76.00 · Bull $92.00 · Bear $52.00Analysis 2026-09-01; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-08 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-01 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-08

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-08. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $107.75
Why
Momentum18 · Δ7d -7.3
Value58 · Δ7d -0.0
Sentiment78 · Δ7d -16.7
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • 3 setup hits (3d) with net bullish as of 2026-09-09.
  • • Sentiment remains the lead driver in the composite, 7D delta -16.7.

Contradictions & invalidation

  • • Analyst estimate, rating, and target revisions are unavailable.
  • • Clinical development and Re-Spire execution have no disclosed readout timeline.
  • • The bear case is that high expectations already discount much of the launch trajectory, while clinical development remains date-uncertain and recent insider sales may create pressure.

Catalyst clock

2026-08-12

Q2 2026 commercial and profitability inflection

Lead driver: Sentiment · See AI snapshot
Momentum
18
9% active weight
Current posture
7d trendSoftening
Δ7d
-7.3
Δ21d
-82.2
Value
58
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+9.4
Sentiment
78
62% active weight
Current posture
7d trendSoftening
Δ7d
-16.7
Δ21d
-22.7
Why this grade

Composite grade B. Momentum 18.0 / Value 58.0 / Sentiment 77.5

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-01. Scenario method

B+
Bull case
25%
Probability
Target price
$92.00
Analysis reference price unavailable
Analysis 2026-09-01 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$76.00
Analysis reference price unavailable
Analysis 2026-09-01 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$52.00
Analysis reference price unavailable
Analysis 2026-09-01 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$6.95B
Beta
0.47
Shares Out
89.51M
P/E (TTM) · Derived
-97.0
P/S (TTM)
40.41
P/FCF (TTM) · Derived
52.69
Rev YoY
+1842.7%
EPS YoY
-251.7%
Gross Margin
+92.3%
Op Margin
+37.4%
Net Debt
$7.25M
Current Ratio
2.31
As of 2026-09-08 • Updated nightlySource: Internal modelMethods & Data